消融設備市場規模、佔有率、成長分析（按技術、應用、最終用戶和地區）- 2025 年至 2032 年產業預測

消融設備市場規模預計在 2023 年達到 94 億美元，從 2024 年的 104.2 億美元成長到 2032 年的 238.5 億美元，在預測期內（2025-2032 年）的複合年成長率為 10.9%。

外科手術技術的最新進展反映了醫療保健領域的重大變革，特別是微創手術的興起。隨著世界人口老化和慢性疾病變得越來越複雜，患者正在尋求侵入性較小的治療方法，以盡量減少術後壓力。微創手術，包括汽化、冷凍療法和射頻等消融技術，具有減輕疼痛、縮短住院時間和加速恢復時間等好處。透過消融術去除腫瘤和進行組織治療正獲得越來越多的支持，因為它比傳統手術侵入性更小。隨著癌症和心血管疾病等慢性疾病變得越來越普遍，對消融設備的需求預計將飆升，凸顯了患者照護和外科手術創新的重要趨勢。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

消融設備市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 射頻設備
• 雷射/光消融
• 超音波設備
• 冷凍消融裝置
• 其他技術

消融設備市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 心臟病學
• 腫瘤學
• 眼科
• 婦科
• 泌尿系統
• 整容手術
• 其他用途

消融設備市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 門診手術中心
• 其他最終用戶

消融設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Johnson & Johnson（USA）
• AngioDynamics, Inc.（USA）
• AtriCure, Inc.（USA）
• Olympus Corporation（Japan）
• Smith & Nephew plc（UK）
• Stryker Corporation（USA）
• Avanos Medical, Inc.（USA）
• Hologic, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips NV（Netherlands）
• Baylis Medical Company, Inc.（Canada）
• Elekta AB（Sweden）
• Haifu Medical Technology Co., Ltd.（China）
• Apyx Medical（formerly Bovie Medical）（USA）
• LeMaitre Vascular, Inc.（USA）
• Alcon Laboratories, Inc.（USA）
• Biotronik SE & Co. KG（Germany）

結論和建議

Ablation Devices Market size was valued at USD 9.4 billion in 2023 and is poised to grow from USD 10.42 billion in 2024 to USD 23.85 billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

Recent advancements in surgical methods reflect a significant transformation within the healthcare sector, especially with the rise of minimally invasive surgery. As the global population ages and the complexity of chronic diseases increases, patients increasingly seek less disruptive treatment options that minimize post-surgical stress. Minimally invasive procedures, including ablation techniques-such as vaporization, freezing, and radiofrequency-offer benefits of reduced pain, shorter hospital stays, and faster recovery times. This shift toward ablation for tumor removal and tissue treatment has gained traction due to its less intrusive nature compared to traditional surgeries. As chronic conditions like cancer and cardiovascular disease become more prevalent, the demand for ablation devices is expected to surge, highlighting a critical trend in patient care and surgical innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Ablation Devices Market Segments Analysis

Global Ablation Devices Market is segmented by Technology, Application, End-user and region. Based on Technology, the market is segmented into Radiofrequency devices, Laser/light ablation, Ultrasound devices, Cryoablation devices and Other technologies. Based on Application, the market is segmented into Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic surgery and Other applications. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Ablation Devices Market

A significant factor driving the growth of the Ablation Devices market is the growing preference among patients for minimally invasive procedures instead of traditional open surgeries. In recent years, there has been a marked rise in the adoption and acceptance of minimally invasive therapies, largely due to their advantages, such as shorter hospital stays, quicker recovery times, and reduced discomfort when compared to conventional surgical methods. Additionally, the increasing prevalence of atrial fibrillation within the population is expected to lead to more cardiac ablation procedures. The ablation method for treating atrial fibrillation offers effective results with lower risks and enhanced convenience for patients. Consequently, the shift towards less invasive treatment options, combined with the increasing use of ablation devices, will significantly drive market growth in the coming years.

Restraints in the Ablation Devices Market

The Ablation Devices market faces substantial limitations due to the insufficient availability of effective conventional first-line medications for conditions like liver cancer, uterine fibroids, haemorrhagic stroke, and various haemorrhagic disorders. The dominant preference for therapies such as surgery, chemotherapy, and radiation is a major barrier, largely stemming from the high level of public awareness surrounding traditional cancer treatments. Additionally, the limited adoption of advanced treatment alternatives, especially in developing regions, coupled with oncologists' hesitance to move away from established treatment protocols, further exacerbates this issue. This resistance to embrace innovative solutions significantly hampers market growth.

Market Trends of the Ablation Devices Market

The Ablation Devices market is poised for significant growth in untapped regions such as Asia-Pacific, Africa, and Latin America, driven by advancements in ablation technologies and rising demand for minimally invasive therapies. Increasing disposable incomes in these areas further enhance market potential. Concurrently, the large undiagnosed patient population and rapid urbanization, which correlate with a rise in chronic illnesses, coupled with heightened awareness of conditions like prostate cancer, are catalysts for demand. Furthermore, augmented government funding for healthcare initiatives is anticipated to propel market expansion in these regions, making them increasingly attractive for industry stakeholders.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Ablation Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency devices
• Laser/light ablation
• Ultrasound devices
• Cryoablation devices
• Other technologies

Global Ablation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Ophthalmology
• Gynecology
• Urology
• Cosmetic surgery
• Other applications

Global Ablation Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory surgical centers
• Other end users

Global Ablation Devices Market Size & CAGR (2025-2032)

• North America (Technology, Application, End-user)
  • US
  • Canada
• Europe (Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylis Medical Company, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apyx Medical (formerly Bovie Medical) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations